• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24657
Medical Device Problem Code Premature Activation (1484)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/01/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that inadvertent deployment occurred.A 6m x 150mm, 130 cm eluvia drug-eluting vascular stent system was selected for use.However, during preparation, it was observed that the stent was partially deployed while still in the package.The product was not used.The procedure was completed using an alternate device.No patient complications were reported.
 
Additional Manufacturer Narrative
Duplicate reports were submitted for this event.Any additional information pertaining to the event will be submitted under emdr 2124215-2024-53102.Device eval by manufacturer: returned product consisted of an eluvia drug-eluting vascular stent system.The outer sheath, tip, inner sheath, and the remainder of the device were checked for damage.Visual examination revealed multiple kinks to the sheath.The stent was partially deployed 3mm from the distal end of the middle sheath.Microscopic examination revealed no additional damages.The thumbwheel lock and pull rack were still in the manufactured position.Inspection of the remainder of the device revealed no other damage or irregularities.Product analysis found damage that would have contributed to the inadvertent deployment.
 
Event or Problem Description
It was reported that inadvertent deployment occurred.A 6m x 150mm, 130 cm eluvia drug-eluting vascular stent system was selected for use.However, during preparation, it was observed that the stent was partially deployed while still in the package.The product was not used.The procedure was completed using an alternate device.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key20064298
Report Number2124215-2024-53102
Device Sequence Number15660048
Product Code NIU
UDI-Device Identifier08714729876625
UDI-Public08714729876625
Combination Product (Y/N)Y
Initial Reporter StateCT
Initial Reporter CountryUS
PMA/510(K) Number
P180011
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/25/2025
Device Model Number24657
Device Catalogue Number24657
Device Lot Number0031852483
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/02/2024
Supplement Date Received by Manufacturer09/10/2024
Initial Report FDA Received Date08/26/2024
Supplement Report FDA Received Date10/04/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/26/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-